A meta-analysis
1 of existing randomized clinical trials suggests that the benefits and risks of surgery compared with conservative management vary, or are heterogeneous, across patients with proximal humerus fracture (PHF). The continued use of surgery over time suggests that surgeons have observed many patients improve after surgical treatment.
2,3 In addition, lower surgery rates for more elderly patients with PHF suggest that surgeons recognize that the risks of surgery (eg, surgical complications, infections, and mortality) increase with patient complexity.
4